Cargando…
Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™)
AIM/INTRODUCTION: Studies on a novel point‐of‐care device for nerve conduction study called DPNCheck have been limited to Westerners. We aimed to clarify Japanese normal limits of nerve action potential amplitude (Amp) and conduction velocity by DPNCheck (investigation I), and the validity of DPNChe...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123044/ https://www.ncbi.nlm.nih.gov/pubmed/29430866 http://dx.doi.org/10.1111/jdi.12818 |
_version_ | 1783352779334483968 |
---|---|
author | Hirayasu, Kazuhiro Sasaki, Hideyuki Kishimoto, Shohei Kurisu, Seigo Noda, Koji Ogawa, Kenichi Tanaka, Hiroto Sakakibara, Yumiko Matsuno, Shohei Furuta, Hiroto Arita, Mikio Naka, Keigo Nanjo, Kishio |
author_facet | Hirayasu, Kazuhiro Sasaki, Hideyuki Kishimoto, Shohei Kurisu, Seigo Noda, Koji Ogawa, Kenichi Tanaka, Hiroto Sakakibara, Yumiko Matsuno, Shohei Furuta, Hiroto Arita, Mikio Naka, Keigo Nanjo, Kishio |
author_sort | Hirayasu, Kazuhiro |
collection | PubMed |
description | AIM/INTRODUCTION: Studies on a novel point‐of‐care device for nerve conduction study called DPNCheck have been limited to Westerners. We aimed to clarify Japanese normal limits of nerve action potential amplitude (Amp) and conduction velocity by DPNCheck (investigation I), and the validity of DPNCheck to identify diabetic symmetric sensorimotor polyneuropathy (DSPN; investigation II). MATERIALS AND METHODS: For investigation I, 463 non‐neuropathic Japanese participants underwent DPNCheck examinations. Regression formulas calculating the normal limits of Amp and conduction velocity (Japanese regression formulas [JRF]) were determined by quantile regression and then compared with regression formulas of individuals from the USA (USRF). For investigation II, in 92 Japanese diabetes patients, ‘probable DSPN’ was diagnosed and nerve conduction abnormalities (NCA1: one or more abnormalities, and NCA2: two abnormalities in Amp and conduction velocity) were determined. Validity of NCAs to identify ‘probable DSPN’ was evaluated by determining sensitivity, specificity, reproducibility (kappa‐coefficient) and the area under the curve of receiver operating characteristic curves. RESULTS: For investigation I, JRF was different from USRF, and normal limits by JRF were higher than that of USRF. The prevalence of Amp abnormality calculated by JRF was significantly higher than that of USRF. For investigation II, the sensitivity, specificity and reproducibility of NCA1 and NCA2 judged from JRF were 85%, 86% and 0.57, and 43%, 100% and 0.56, respectively. These values of JRF were higher than those of USRF. The area under the curve of JRF (0.89) was larger than USRF (0.82). CONCLUSIONS: A significant difference in the normal limits of nerve conduction parameters by DPNCheck between Japanese and USA individuals was suggested. Validity to identify DSPN of NCAs might improve by changing the judgment criteria from USRF to JRF. |
format | Online Article Text |
id | pubmed-6123044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61230442018-09-06 Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™) Hirayasu, Kazuhiro Sasaki, Hideyuki Kishimoto, Shohei Kurisu, Seigo Noda, Koji Ogawa, Kenichi Tanaka, Hiroto Sakakibara, Yumiko Matsuno, Shohei Furuta, Hiroto Arita, Mikio Naka, Keigo Nanjo, Kishio J Diabetes Investig Articles AIM/INTRODUCTION: Studies on a novel point‐of‐care device for nerve conduction study called DPNCheck have been limited to Westerners. We aimed to clarify Japanese normal limits of nerve action potential amplitude (Amp) and conduction velocity by DPNCheck (investigation I), and the validity of DPNCheck to identify diabetic symmetric sensorimotor polyneuropathy (DSPN; investigation II). MATERIALS AND METHODS: For investigation I, 463 non‐neuropathic Japanese participants underwent DPNCheck examinations. Regression formulas calculating the normal limits of Amp and conduction velocity (Japanese regression formulas [JRF]) were determined by quantile regression and then compared with regression formulas of individuals from the USA (USRF). For investigation II, in 92 Japanese diabetes patients, ‘probable DSPN’ was diagnosed and nerve conduction abnormalities (NCA1: one or more abnormalities, and NCA2: two abnormalities in Amp and conduction velocity) were determined. Validity of NCAs to identify ‘probable DSPN’ was evaluated by determining sensitivity, specificity, reproducibility (kappa‐coefficient) and the area under the curve of receiver operating characteristic curves. RESULTS: For investigation I, JRF was different from USRF, and normal limits by JRF were higher than that of USRF. The prevalence of Amp abnormality calculated by JRF was significantly higher than that of USRF. For investigation II, the sensitivity, specificity and reproducibility of NCA1 and NCA2 judged from JRF were 85%, 86% and 0.57, and 43%, 100% and 0.56, respectively. These values of JRF were higher than those of USRF. The area under the curve of JRF (0.89) was larger than USRF (0.82). CONCLUSIONS: A significant difference in the normal limits of nerve conduction parameters by DPNCheck between Japanese and USA individuals was suggested. Validity to identify DSPN of NCAs might improve by changing the judgment criteria from USRF to JRF. John Wiley and Sons Inc. 2018-03-06 2018-09 /pmc/articles/PMC6123044/ /pubmed/29430866 http://dx.doi.org/10.1111/jdi.12818 Text en © 2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Articles Hirayasu, Kazuhiro Sasaki, Hideyuki Kishimoto, Shohei Kurisu, Seigo Noda, Koji Ogawa, Kenichi Tanaka, Hiroto Sakakibara, Yumiko Matsuno, Shohei Furuta, Hiroto Arita, Mikio Naka, Keigo Nanjo, Kishio Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™) |
title | Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™) |
title_full | Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™) |
title_fullStr | Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™) |
title_full_unstemmed | Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™) |
title_short | Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™) |
title_sort | difference in normal limit values of nerve conduction parameters between westerners and japanese people might need to be considered when diagnosing diabetic polyneuropathy using a point‐of‐care sural nerve conduction device (nc‐stat®/dpncheck™) |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123044/ https://www.ncbi.nlm.nih.gov/pubmed/29430866 http://dx.doi.org/10.1111/jdi.12818 |
work_keys_str_mv | AT hirayasukazuhiro differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck AT sasakihideyuki differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck AT kishimotoshohei differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck AT kurisuseigo differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck AT nodakoji differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck AT ogawakenichi differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck AT tanakahiroto differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck AT sakakibarayumiko differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck AT matsunoshohei differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck AT furutahiroto differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck AT aritamikio differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck AT nakakeigo differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck AT nanjokishio differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck |